This multicenter randomized clinical trial conducted in Canada assesses whether 30-day all-cause mortality differs with the use of radial access or femoral access for primary percutaneous coronary intervention among referred patients with ST-segment elevation myocardial infarction.
This cohort study assesses temporal trends in 30-day readmission and mortality rates among black and nonblack patients discharged after hospitalization for acute myocardial infarction at hospitals defined as low-performing and high-performing per their Hospital Readmissions Reduction Program penalty status.
This cohort study of 454 patients with stable coronary artery disease investigates the association between the change in circulating progenitor cell counts during exercise and the risk of adverse cardiovascular events among patients with and without stress-induced myocardial ischemia.
This cohort study of Medicare beneficiaries compares 30-day vs 90-day mortality as a hospital performance metric for transcatheter aortic valve replacement and surgical aortic valve replacement.
This case series examines the association between use of hearts from hepatitis C–positive donors for US patients undergoing heart transplant and heart transplant volumes, wait-list duration, the transmission and cure of donor-derived hepatitis C, and morbidity and mortality at 1 year.
This registry-based cohort study analyzes the association between varying combinations of neurohormonal blockade therapies and survival and quality of life in adult patients with left ventricular assist devices.
This cohort study describes the trajectory of albuminuria as measured by urine albumin-to-creatinine ratio across a 20-year span and evaluates the association of albuminuria trajectory with echocardiographic indices of structure and function in middle age.
This prespecified analysis of the PROMISE randomized clinical trial determines whether the prognostic utility of anatomic vs functional testing for coronary artery disease varies based on patient age.
This secondary analysis of the PIONEER-HF trial explores the association between patients with chronic heart failure switching from taking enalapril to taking sacubitril/valsartan with N-terminal pro–B-type natriuretic peptide levels.
This cohort study examines the drug eligibility of 12 cardiovascular drugs recently tested in several randomized clinical trials for Danish patients with known ischemic heart disease or prior myocardial infarction.
This Viewpoint examines the ability of a marginal gains approach to improve interventional outcomes in cardiology.
This article describes an observation of jugular venous distention in Michelangelo’s David and its relevance to clinical cardiology.
This guideline presents updated recommendations for management of familial hypercholesterolemia.
This case report describes a woman with active bulimia, syncope after palpitations, and an abnormal heart rhythm. What would you do next?